The Genetics Generation Advancement Corporation under the BIONET Corporation focuses on 5 major areas in precision medicine: maternal-fetal medicine, pediatric diseases, companion diagnostics, cancer screening, and precision health management. The company also expands its expertise and applies to consumer’s market with clinical standards by releasing diverse genetic testing for all ages, which combines big data analysis of biological information and connects with national medical plans to provide a complete, innovative, and integrated service.
First place achievements:
▸ The first listed company at stock exchange market specializing in genetic testing and scientific informatics in Taiwan.
▸ The first company in Taiwan that releases genetic testing for spinal muscular atrophy (SMA), second trimester maternal serum screening of 4 indexes for Down syndrome, and pre-implantation genetic diagnosis (PGD, UltraPGD).
▸ The first laboratory in Taiwan that received accreditation by College of American Pathologists (CAP), Taiwan Accreditation Foundation (TAF), Affymetrix®, and Illumina® CSPro, and passed test for hepatitis C virus NS5A mutation analysis by Taiwanese Society of Molecular Medicine.
▸ Serving 40% of newborn babies in Taiwan each year.
▸ Establishing over 1.2 million pieces of medical big data.
▸ Testing services that encompass 11 countries over continents of Asia, Europe, and America.
▸ Cooperation with over 100 institutes from industry, government, academia, and research.
▸ Cooperation with 95% of domestic pregnancy testing facilities and many professional testing institutes.
▸ The first to establish a genetic counseling team that integrates genetic testing to provide genetic medical services.
▸ The first to introduce SNP chips to expand prenatal screening to pediatric disease diagnosis.
▸ The first to form a NIPT team with Natera (USA) and Berry Genomics (China) to provide complete prenatal testing services.
▸ Spending millions of dollars each year to help reporting abnormal fetuses and provide free microarray comparisons of parental blood to further clarify the risk.
Cooperation projects and needs
1. Sincerely invites all domestic and foreign research institutes, medical facilities, and related health examination centers for cooperative works.